![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Stone, John H.; Tuckwell, Katie; Dimonaco, Sophie; Klearman, Micki; Aringer, Martin; Blockmans, Daniel; Brouwer, Elisabeth; Cid, Maria C.; Dasgupta, Bhaskar; Rech, Jürgen; Salvarani, Carlo; Schulze-Koops, Hendrik; Schett, Georg; Spiera, Robert; Unizony, Sebastian H. und Collinson, Neil
(2019):
Glucocorticoid Dosages and Acute-Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab.
In: Arthritis & Rheumatology, Bd. 71, Nr. 8: S. 1329-1338
Vastesaeger, Nathan; Kutzbach, Abraham Garcia; Amital, Howard; Pavelka, Karel; Alicia Lazaro, Maria; Moots, Robert J.; Wollenhaupt, Jürgen; Zerbini, Cristiano A. F.; Louw, Ingrid; Combe, Bernard; Beaulieu, Andre; Schulze-Koops, Hendrik; Dasgupta, Bhaskar; Fu, Bo; Huyck, Susan; Weng, Haoling H.; Govoni, Marinella und Durez, Patrick
(2016):
Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab.
In: Rheumatology, Bd. 55, Nr. 8: S. 1466-1476
Combe, Bernard; Dasgupta, Bhaskar; Louw, Ingrid; Pal, Sarvajeet; Wollenhaupt, Jürgen; Zerbini, Cristiano A. F.; Beaulieu, Andre D.; Schulze-Koops, Hendrik; Durez, Patrick; Yao, Ruji; Vastesaeger, Nathan und Weng, Haoling H.
(2014):
Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study.
In: Annals of the rheumatic diseases, Bd. 73, Nr. 8: S. 1477-1486
[PDF, 1MB]